Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.
暂无分享,去创建一个
D. Fukai | M. Kinoshita | Y. Sugimoto | T. Tsutamoto | K. Maeda | T. Hisanaga | A. Wada | Y. Maeda | M. Ohnishi
[1] R. T. Lie,et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. , 1996, Circulation.
[2] D. Fukai,et al. Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure. , 1995, American Journal of Cardiology.
[3] H. Itoh,et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. , 1995, Circulation.
[4] R. T. Lie,et al. Neurohumoral measurements as indicators of long-term prognosis after acute myocardial infarction. , 1995, The American journal of cardiology.
[5] S. Yusuf,et al. Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction , 1995 .
[6] J. Rouleau,et al. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. , 1994, Journal of the American College of Cardiology.
[7] M. Kinoshita,et al. Plasma Arteriovenous cGMP Difference as a Useful Indicator of Nitrate Tolerance in Patients With Heart Failure , 1994, Circulation.
[8] K. Kugiyama,et al. Localization and Mechanism of Secretion of B‐Type Natriuretic Peptide in Comparison With Those of A‐Type Natriuretic Peptide in Normal Subjects and Patients With Heart Failure , 1994, Circulation.
[9] M. Kinoshita,et al. Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure. , 1994, Journal of the American College of Cardiology.
[10] Y. Matsuda,et al. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors. , 1994, Circulation.
[11] G. Lamas,et al. N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction. , 1994, Circulation.
[12] K. Nakao,et al. Increased Plasma Levels of Brain Natriuretic Peptide in Patients With Acute Myocardial Infarction , 1993, Circulation.
[13] A. Struthers,et al. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction , 1993, The Lancet.
[14] Michihisa Jougasaki,et al. Different Secretion Patterns of Atrial Natriuretic Peptide and Brain Natriuretic Peptide in Patients With Congestive Heart Failure , 1993, Circulation.
[15] M. Kinoshita,et al. Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure. , 1993, Circulation.
[16] P. Binkley,et al. Plasma Endothelin Correlates With the Extent of Pulmonary Hypertension in Patients With Chronic Congestive Heart Failure , 1992, Circulation.
[17] M. Kinoshita,et al. Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure. , 1991, Journal of the American College of Cardiology.
[18] H. Imura,et al. Hemodynamic, Renal, and Hormonal Responses to Brain Natriuretic Peptide Infusion in Patients With Congestive Heart Failure , 1991, Circulation.
[19] J. Remes,et al. Neuroendocrine activity in untreated heart failure. , 1991, British heart journal.
[20] D. Stewart,et al. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? , 1991, Annals of internal medicine.
[21] K. Nakao,et al. Biosynthesis, secretion, and receptor selectivity of human brain natriuretic peptide. , 1991, Canadian journal of physiology and pharmacology.
[22] K. Swedberg,et al. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. , 1990, Circulation.
[23] L. Shapiro,et al. Balloon dilatation of tricuspid stenosis caused by carcinoid heart disease , 1990, British heart journal.
[24] S. Gottlieb,et al. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. , 1989, Journal of the American College of Cardiology.
[25] M. Shichiri,et al. Vasoconstrictor-induced heterologous down-regulation of vascular atrial natriuretic peptide receptor. , 1989, European journal of pharmacology.
[26] N. Minamino,et al. Cloning and sequence analysis of cDNA encoding a precursor for rat brain natriuretic peptide. , 1989, Biochemical and biophysical research communications.
[27] D. Goeddel,et al. A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor , 1989, Nature.
[28] M. Kinoshita,et al. Plasma atrial natriuretic polypeptide as an index of left ventricular end-diastolic pressure in patients with chronic left-sided heart failure. , 1989, American heart journal.
[29] M. Packer,et al. Neurohormonal interactions and adaptations in congestive heart failure. , 1988, Circulation.
[30] Naoto Minamino,et al. A new natriuretic peptide in porcine brain , 1988, Nature.
[31] P. Hamet,et al. Effects of Atrial Natriuretic Factor on Natriuresis and cGMP in Patients with Essential Hypertension , 1987, Journal of hypertension.
[32] H. Ives,et al. In vivo evidence that cGMP is the second messenger for atrial natriuretic factor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[33] P. Erne,et al. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. , 1986, The New England journal of medicine.
[34] R. Rodeheffer,et al. Atrial pressure and secretion of atrial natriuretic factor into the human central circulation. , 1986, Journal of the American College of Cardiology.
[35] E. Bates,et al. The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man. , 1986, Circulation.
[36] R. Gerzer,et al. Rapid increase in plasma and urinary cyclic GMP after bolus injection of atrial natriuretic factor in man. , 1985, The Journal of clinical endocrinology and metabolism.
[37] J. Cohn,et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.
[38] J. Cohn,et al. The neurohumoral axis in congestive heart failure. , 1984, Annals of internal medicine.